SCIENTIFIC BACKGROUND

CACNA1S, RYR1

Scientific Background

Malignant hyperthermia (MH) is a genetic Ca2+ regulatory disorder of skeletal muscle. In genetically predisposed individuals, the administration of volatile anesthetics (fluranes) and depolarising muscle relaxants (e.g., suxamethasone) can lead to a potentially life-threatening hypermetabolism. The symptoms are very variable and range from moderate forms with low severity to a severe, sudden (fulminant) MH crisis. In the early phase, classic signs of a fulminant MH crisis are tachycardia, hypercapnia, hypoxemia and masseter spasms; in the late phase, acidosis, hyperkalemia, rhabdomyolysis and hyperthermia are added. The antidote dantrolene has reduced the mortality rate in MH crises to <5%. The prevalence of MH in the German population is estimated at 1:10,000. The incidence of a fulminant MH crisis is about 1:60.000. In predisposed patients, the administration of trigger substances must be avoided. Without trigger substances, myopathy is usually inapparent.

 

Pathogenic variants in the ryanodine receptor 1 (RYR1) and the dihydropyridine receptor (voltage-dependent L-type calcium channel, CACNA1S) are associated with a predisposition for MH. Heredity is autosomal dominant with incomplete penetrance. Variants in one of these genes could be identified in about 75% of MH families. The detection of a causative variant enables the identification of other relatives at risk by means of target diagnostics. However, so far only about 50 variants have been categorized as causative by the European Malignant Hyperthermia Group (EMHG). In addition, the studies did not identify variants in the RYR1 or CACNA1S gene in all affected patients, so that a negative molecular genetic finding does not rule out the presence of MH. Therefore, where suspicion exists and there are negative genetic findings or if variants of unclear significance are detected, an in vitro muscle contraction test (IVCT) should be performed to confirm the diagnosis.

 

References

Gonsalves et al. 2019, Clin Pharmacol Ther 105:1338

GENES

CACNA1S, RYR1

ASSOCIATED TESTS

How to order

LATEST ARTICLES

Have you ever wondered how jet-setting across the globe might affect your gut health? A recent study has dug into this intriguing question, revealing...

Read more

In June 2023, Medicover Genetics attended the 56th conference of the European Society of Human Genetics (ESHG) which took place in Glasgow, Scotland....

Read more

Vitamin D, also known as “the sunshine vitamin”, is a fat-soluble vitamin that helps the body absorb calcium and phosphate, which are essential f...

Read more

Every movement our body makes is controlled by a long, thin, tube-like structure called the “spinal cord”. The spinal cord is part of our nervous...

Read more

Genetic variant databases are vital for interpreting genetic variations in clinical settings and research. However, misclassified variants can create...

Read more

A recent article published by our team in the International Journal of Molecular Sciences [1], aimed to evaluate the prevalence, prognostic and predi...

Read more

A healthy, nutritious and well-balanced diet is always important for a person’s well-being, and it is even more so during pregnancy as the developi...

Read more

The sun is hot and you are sweating. Most of us know how it feels to sweat, and when we sweat. This is a normal bodily response to an increase in tem...

Read more

All about the pancreas The pancreas is a pear-shaped organ that is located at the upper left side of the abdomen, behind the stomach. It has two m...

Read more

The father of genetics is Gregor Mendel. Mendel was an Austrian monk, whose experiments breeding pea plants in the monastery garden led to breakthrou...

Read more